Eric Lefkofsky is the co-founder and CEO of Tempus. He is a self-made billionaire. Eric Lefkofsky grew up Southfield, Michigan. He was the son of a structural engineer Bill Lefkofsky and Sandy Lefkofsky as schoolteacher. Upon graduating high school, he attended the University of Michigan in the year 1987. He later graduated in the year 1991, with top honors. However, he continued his education in University of Michigan School of law where he obtained his Juris Doctor in 1993. After completing his studies, he and his campus friend, decided to purchase Bradon Apparel with the capital they had borrowed from their relatives.
However, he love for technology led him to create Tempus. Tempus is a health-technology company that is in the process of building the world’s largest infrastructure to help modernize the treatment of cancer. The company was founded in 2015, to help consolidate, merge, clean up, and digitize cancer patients’ clinical information. The consolidation of this information will help physicians learn more about cancer for the data and help more people in the future. To ensure the aim of Tempus is accomplished they include molecular data through DNA sequencing. Tempus has established a sequence of data pipelines that help cleanse, collect, and analyze the molecular and clinical data.
Their efforts will help usher in the use of precision medicine. The aim of the entire process Tempus undertakes is to ensure that every cancer patient’s molecular and clinical data is in one place. Having the data in one place will assist the physicians to make data-driven and real-time decisions with their clients. The data will also help physicians learn more about cancer from the patient’s information. It will also give physicians a clue on how to manage it with the treatment options available.
With the strides Tempus has taken to ensure the success of their work, it has earned them a spot on the top ten health technology in Chicago. Tempus has also established various partnerships with several academic and health institutions. The information they offer the institutions especially the health institutions proves helpful when it comes to assisting cancer patients.
About Eric Lefkofsky: www.crunchbase.com/person/eric-lefkofsky
Summary about Jim and Recap of interview with Ideasmench:
Every career path is unique and personal, but few are quite as impressive as Jim Tananbaum’s. Jim himself majored at Yale University in math, electrical engineering and computer science and then obtained his M.S. from MIT in 1989. If that wasn’t enough, he subsequently obtained his M.D. and MBA from Harvard University. Despite all of this and his many professional achievements, Jim tells Ideasmench that if he could do it all again, he would have believed in himself more and made fewer compromises. Jim is passionate about making opportunities for interdisciplinary hard sciences and computer science to intersect with healthcare. More than a decade before founding Foresite, he began incubating the idea that a large dedicated healthcare fund would be more competitive, but he was more risk averse at the time. During his interview with Ideasmench, Jim shared that one of his failures as an entrepreneur was a catalyst for founding Foresite. He was a senior partner at a fund and missed more than a few opportunities to invest in companies he felt good about, despite having the resources to do so – all because of fear of the current financial market. So in 2011, Jim founded Foresite Capital – a private equity firm that provides capital and support to help companies with transformative products and services become healthcare leaders. Jim tells Ideasmench that what he learned from his experiences is that you have to take risks and go with your gut, “It’s about disruption, not convention.”
Then, write a couple paragraphs about Jim Tananbaum and his professional life in general.
After attending higher education for a decade, Jim co-founded and ran GelTex, a pharmaceutical company focused on developing non-systemic drugs and within 2 years it was acquired by Genzyme for $1.6B. Jim remained a Board Member for the company for another 4 years. During that time he joined Sierra Ventures as a Partner, where he built their Healthcare Service Investment Practice. After 4 years with Sierra, Jim co-founded and led another biopharmaceutical company – Theravance. In 2001, Jim Tananbaum returned to the venture capital field and co-founded Prospect Venture Partners. After leading this firm for 9 years, he founded Foresite Capital Management, where he has been the CEO for 7 years.
Not only is Jim Tananbaum a successful entrepreneur, is on Yale University’s President’s Advisory Board and an Advisor at Harvard, and is highly educated across a variety of STEM fields, but he somehow makes time for family, friends, and remaining physically fit. He is also very down to earth and is always willing to share from his experiences and encourage other entrepreneurs. You can visit Business profile for more info.